Perrigo enters softgel space buying ex-Banner operations for $34m from Patheon
Patheon has sold its Mexican operations to Perrigo for $34m as it looks to transform the Banner business it acquired back in 2012.
Patheon has sold its Mexican operations to Perrigo for $34m as it looks to transform the Banner business it acquired back in 2012.
SAFC has announced investments in gene therapy manufacturing sites in Missouri and California.
The EMA (European Medicines Agency) is changing the way it assesses quality of topical drugs for marketing authorisations.
The debate continues over how to optimize clinical trials, with some experts calling for incremental changes to combat inefficiencies while the FDA’s deputy commissioner says the industry is at a “tipping point.”
A lack of scientific talent will hold pharma back from adopting continuous manufacturing despite the imminent opening of regulatory pathways, says an MIT Professor.